Brian NEEDHAM

En résumé

Entreprises

• Quadrant Healthcare - Senior Strategy Consultant

  2018 - maintenant - Strategy consultant for multinational pharmaceutical firms
  - Advise global and affiliate market access, medical, and commercial product leads on strategic issues
  - Gain interdisciplinary and international alignment on key topics such as launch readiness, value story, strategic plan, evidence gaps, etc.

• Monitor Deloitte - Strategy Consultant

  2016 - 2018 - Conducted EU market access and pricing strategy for biopharmaceuticals
  - Provided strategic review of multi-million pound NHS quality and cost improvement programs
  - Designed leadership development program for emerging leaders in medical social science research in collaboration with one of the world's largest medical charities

• Various - Senior Strategy Consultant

  2013 - maintenant

• Deloitte Consulting - Senior Consultant

  Puteaux 2013 - 2016 - Designed and led development of an analytical tool that allows clients and consulting teams to use proprietary and third-party data to objectively assess a client's ambulatory footprint and generate recommendations related to potential liquidation, consolidation, or growth of physical assets
  - Led design of an ambulatory quality dashboard for network of 5,000+ physicians to be used by executives and physicians alike in enabling better quality of care for patients
  - Contributed to developing the firm's Physician Enterprise and Ambulatory Services and Value Based Care communities; delivered trainings on value-based care in America and India
  - Conducted benchmarking analysis and led workgroups attended by both physicians and administrators to drive operating margin improvement among a leading academic medical center's ambulatory clinics
  - Led national communications and branding team for consultants directly hired into the firm
  - Supported project management team of $350M, 7 work-stream initiative

• Technology Entrepreneurship & Commercialization Institute - Senior Analyst, life sciences and health

  2011 - 2013 - Managed projects for the Director of the TEC Institute pertaining to information technology, process improvement, and quality control
  - Assisted in evaluating projects from various University departments related primarily to the development of novel therapeutic or diagnostic drug candidates
  - Worked on individual projects and on establishing sustainable systems within the TEC Institute including a system for triaging early-stage, high-potential technologies
  - Collaborated with lead investigators and with the staff of the newly formed Drug Development Institute at the James Cancer Center
  - Led team of 6 analysts in the evaluation of the commercial potential of healthcare technologies for informing internal funding decisions

Formations

• London School Of Economics And Political Science (London)

  London 2019 - 2021 Master of Science
  
  Executive MSc program (4 weeks / year), completed during vacation time (congées payées)

• London School Of Economics And Political Science (London)

  London 2019 - maintenant Executive MSc

• The Ohio State University (Columbus)

  Columbus 2010 - 2013 MBA
  
  GRE Q:168/V:166/A:5.5; GPA 3.8; International Field Study: India
  Fellowships awarded: FLAS Fellowship, Quechua; Ellis II MBA Fellowship; Schweitzer
  Fellowship; Columbus Hospitals Fund Scholarship

• James Madison University (Harrisonburg)

  Harrisonburg 2006 - 2010 Bachelor of Business Administration
  
  BS in Health Services Administration, cum laude
  GPA 3.6; Semester abroad: London, UK
  Honors Thesis: ``An Overview of Contributing Factors to the Capital Budgeting Techniques of U.S. Hospitals''

Réseau

Pas de contact professionnel